vTv Therapeutics (VTVT) Non-Current Debt (2014 - 2023)

vTv Therapeutics has disclosed Non-Current Debt across 10 years of filings, most recently posting $191000.0 for Q4 2023.

• In Q4 2023, Non-Current Debt fell 14.73% year-over-year to $191000.0; the TTM figure through Dec 2023 stood at $191000.0 (down 14.73% YoY), while the FY2023 annual figure was $191000.0, down 14.73% from the prior year.
• Non-Current Debt came in at $191000.0 for Q4 2023 at vTv Therapeutics, down from $922000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $4.5 million in Q1 2021 to a low of $191000.0 in Q4 2023.
• Average Non-Current Debt over 5 years is $2.1 million, with a median of $2.2 million recorded in 2019.
• Year-over-year, Non-Current Debt jumped 61.51% in 2020 and slumped 82.96% in 2022.
• Over 5 years, Non-Current Debt stood at $2.6 million in 2019, then climbed by 10.38% to $2.9 million in 2020, then plunged by 56.04% to $1.3 million in 2021, then tumbled by 82.25% to $224000.0 in 2022, then retreated by 14.73% to $191000.0 in 2023.
• Per Business Quant data, the three most recent Non-Current Debt figures were $191000.0 in Q4 2023, $922000.0 in Q1 2023, and $224000.0 in Q4 2022.